---
title: "BLUE SAIL MEDICAL released its performance for the first three quarters, with a net loss attributable to the parent company of 286 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263487992.md"
description: "According to the Zhitong Finance APP, BLUE SAIL MEDICAL released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 4.182 billion yuan, a year-on-year decrease of 10.15%. The net loss attributable to shareholders of the listed company was 286 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 364 million yuan. The basic loss per share was 0.28 yuan"
datetime: "2025-10-30T10:36:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263487992.md)
  - [en](https://longbridge.com/en/news/263487992.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263487992.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263487992.md) | [繁體中文](https://longbridge.com/zh-HK/news/263487992.md)


# BLUE SAIL MEDICAL released its performance for the first three quarters, with a net loss attributable to the parent company of 286 million yuan

According to the Zhitong Finance APP, BLUE SAIL MEDICAL (002382.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 4.182 billion yuan, a year-on-year decrease of 10.15%. The net loss attributable to shareholders of the listed company was 286 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 364 million yuan. The basic loss per share was 0.28 yuan

### Related Stocks

- [BLUE SAIL MEDICAL (002382.CN)](https://longbridge.com/en/quote/002382.CN.md)

## Related News & Research

- [Bug that wiped customer data saved the day – and a contract](https://longbridge.com/en/news/278347746.md)
- [AI X Tech Proposes Dropping Chinese Company Name](https://longbridge.com/en/news/278488333.md)
- [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/en/news/278372421.md)
- [10:07 ETIntune Physical Therapy Expands into Texas with Acquisition of Spero Rehab](https://longbridge.com/en/news/278571095.md)
- [NewLake Capital Faces Liquidity Pressure From Uninsured Bank Deposits Above FDIC Limits](https://longbridge.com/en/news/278204561.md)